Pliant Therapeutics, Inc.

NASDAQ:PLRX

1.73 (USD) • At close September 8, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q1
Omzet 002.270004.84-4.840.2481.3321.9651.4824.9891.2491.9991.611.7892.1744.4654.8143.628.93857.0520000
Kosten van de omzet 0.4470.4481.1350.5320.6220.5130.4641.0451.1041.0611.0531.030.8990.6992.0870.400000000000
Brutowinst -0.447-0.4481.135-0.532-0.622-0.5134.376-2.211-0.8560.2710.9120.4524.090.55-0.0881.211.7892.1744.4654.8143.628.93857.0520000
Brutowinstmarge 000.50000.9040.457-3.4520.2030.4640.3050.820.44-0.0440.75211111110000
Onderzoek- en ontwikkelingskosten 32.19843.43638.79347.75444.99536.63332.71932.33933.00229.27325.11424.60626.33520.88118.75221.05219.21818.52717.85416.88417.53613.91911.72710.77913.09811.7495.018
Algemene en administratieve kosten 13.39415.49914.52714.2615.02215.24613.85415.34614.57414.15414.2518.8238.2968.5797.8467.6715.4756.5665.6274.5913.044.0113.1032.5832.6432.6011.21
Verkoop- en marketingkosten 000000000000000000000000000
Verkoop-, algemene en administratieve kosten 13.39415.49914.52714.2615.02215.24613.85415.34614.57414.15414.2518.8238.2968.5797.8467.6715.4756.5665.6274.5913.044.0113.1032.5832.6432.6011.21
Overige kosten -0.447000000.46400000000000-0.0970.055-0.13600-0.041-0.0210.0140
Bedrijfskosten 45.14558.93553.3262.01460.01751.87947.03747.68547.57643.42739.36533.42934.63129.4626.59828.72324.69325.09323.48121.47520.57617.9314.8313.36215.74114.356.238
Bedrijfsresultaat -45.592-58.935-53.32-62.014-60.639-52.392-47.037-47.685-47.328-42.095-37.4-31.947-29.642-28.211-24.599-27.113-22.904-22.919-19.016-16.661-16.97611.00842.222-13.362-15.741-14.35-6.228
Bedrijfsresultaat ratio 00-23.489000-9.7189.852-190.839-31.603-19.033-21.557-5.941-22.587-12.306-16.84-12.803-10.542-4.259-3.461-4.7160.380.740000
Totaal overige inkomsten en kosten netto 2.2922.7693.5884.2514.7855.4375.9286.1986.1364.5472.341.3320.0960.1110.0680.0680.0730.063-0.0110.127-0.0250.021-0.0530.1070.2190.3270.006
Inkomen voor belasting -43.3-56.166-49.732-57.763-55.854-46.955-41.109-41.487-41.192-37.548-35.06-30.615-29.546-28.1-24.531-27.045-22.831-22.856-19.027-16.534-17.00111.02942.169-13.255-15.522-14.023-6.222
Inkomen voor belasting ratio 00-21.908000-8.4948.572-166.097-28.189-17.842-20.658-5.922-22.498-12.272-16.798-12.762-10.513-4.261-3.435-4.7230.3810.7390000
Belastingkosten 000000000-9.405-0.455-2.6640.269-0.2220-0.012-0.03000-0.1110-0.1150000
Nettowinst -43.3-56.166-49.732-57.763-55.854-46.955-41.109-41.487-41.192-28.143-34.605-27.951-29.546-27.878-24.531-27.045-22.831-22.856-19.027-16.534-17.00111.02940.022-13.255-15.522-14.023-7.104
Nettowinstmarge 00-21.908000-8.4948.572-166.097-21.128-17.611-18.86-5.922-22.32-12.272-16.798-12.762-10.513-4.261-3.435-4.7230.3810.7020000
WPA (Winst Per Aandeel) -0.71-0.92-0.82-0.95-0.92-0.78-0.69-0.7-0.7-0.5-0.71-0.6-0.82-0.77-0.68-0.75-0.64-0.64-0.54-0.47-1.390.511.93-0.61-0.71-0.64-6.88
Verwaterde WPA -0.71-0.92-0.82-0.95-0.92-0.78-0.69-0.7-0.7-0.5-0.71-0.6-0.82-0.77-0.68-0.75-0.64-0.64-0.54-0.47-1.390.481.93-0.58-0.68-0.61-6.88
EBITDA -42.044-54.919-48.44-56.354-54.364-45.997-40.324-40.125-39.769-36.176-33.716-29.585-28.647-27.401-24.181-26.725-22.534-22.56-18.669-16.331-16.65511.3242.512-13.075-15.461-14.094-6.11
EBITDA ratio 00-21.339000-8.3318.29-160.359-27.159-17.158-19.963-5.742-21.938-12.097-16.599-12.596-10.377-4.181-3.392-4.6260.3910.7450000